$51.57
+2.51 (+5.12%)
At Close: Jun 04, 2026
Bone Marrow Market Detail Analysis focusing on Key Players like AGendia, Agilent, Illumina, QIAGEN, Roche, Sanofi, Stryker, PromoCell | Forecasts 2021-2028
11:42am, Tuesday, 16'th Nov 2021 OpenPR
Overview of Global Bone Marrow Market: Market research information of Bone Marrow Market report analyses prime challenges faced by the Healthcare industry currently and in the coming years, which gives idea to other Market participants about the problems they may face
Global Berryliosis Treatment Market Synopsis: The finest Berryliosis Treatment Market analysis document enumerates information about the key companies based on their Market position in the present scenario along with data related to the Market sales gathered by the manufacturers along with
Baker McKenzie advises BNP Paribas and Deutsche Bank on CHF 19 billion bridge financing for Roche
05:13pm, Monday, 15'th Nov 2021 Legal Desire
Baker McKenzie acted for BNP Paribas and Deutsche Bank in connection with their approximately CHF The post Baker McKenzie advises BNP Paribas and Deutsche Bank on CHF 19 billion bridge financing for Roche appeared first on Legal Desire .
RNA Next-Generation Sequencing Market Comprehensive Analysis: Check Latest Strategic Moves of Emerging Players | Roche, Illumina, Thermo Fisher Scientific
04:18pm, Monday, 15'th Nov 2021 OpenPR
Complete study of the global RNA Next-Generation Sequencing market is carried out by the analysts in this report, taking into consideration key factors like drivers, challenges, recent trends, opportunities, advancements, and competitive landscape. This report offers a clear understanding of
Overview of Global Biotechnology Market: The market dynamics study of an influential Biotechnology Market report demonstrates the scope of the various commercial possibilities over the coming years and the positive revenue forecasts in the years ahead. Important industry trends, Market size,
Regeneron (REGN), Roche Get EC Nod for COVID-19 Cocktail
11:35am, Monday, 15'th Nov 2021
Regeneron (REGN) and partner Roche win the European Commission's approval for antibody cocktail to treat and prevent COVID-19.
Coave Therapeutics appoints Chief Medical Officer and Chief Operating Officer
09:15am, Monday, 15'th Nov 2021 Private Equity Wire
Coave Therapeutics appoints Chief Medical Officer and Chief Operating Officer Submitted 15/11/2021 - 9:15am Coave Therapeutics (Coave), a clinical-stage biotechnology company backed by international life science and strategic investors Seroba Life Sciences, Théa Open Innovation, eureKARE, Fund+, Omnes Capital, V-Bio Ventures, Kurma Partners, Idinvest, GO Capital, Sham Innovation Santé/Turenne, has strengthened its leadership team with the appointments of Thomas Blaettler MD, as Chief Medical Officer, and Patricia Françon PhD, to the newly created position of Chief Operating Officer. I am very pleased to welcome Thomas and Patricia to the leadership team at Coave. Their collective accomplishments and deep domain expertise in neuroscience, cell and gene therapy, in addition to their extensive clinical drug development and project management experience will be invaluable as we progress our lead candidate through clinical development and advance our pipeline of novel gene therapies into clinical development targeting rare Ocular and CNS diseases, says Rodolphe Clerval, CEO.
Solar Control Window Films Market is Booming Worldwide | Leica, Roche, Thermo Fisher, Agilent, BioGenex, Sakura Finetek, Intelsint, Biocare
09:10am, Monday, 15'th Nov 2021 OpenPR
Solar Control Window Films Market 2021 research provides a detailed information of the industry including classifications, applications and industry chain structure. The Global Solar Control Window Films Industry analysis is provided for the international markets including development trends, competitive landscape
Parkinsons Disease Drugs Market to reach USD 8,383.2 Million by 2026 | Market Projection By Technology, Major key players, Growth, Revenue, CAGR, Regional Analysis, Industry Forecast
09:08am, Monday, 15'th Nov 2021 Intrado Digital Media
Key Companies in Parkinsons Disease Drugs Market are Pfizer, Roche, Merck, Novartis, Orion Pharma, UCB, Teva Pharmaceutical, Vertical Pharmaceuticals, ACADIA Pharmaceuticals Inc., Impax Laboratories, Lundbeck and Others Key Players Key Companies in Parkinsons Disease Drugs Market are Pfizer, Roche, Merck, Novartis, Orion Pharma, UCB, Teva Pharmaceutical, Vertical Pharmaceuticals, ACADIA Pharmaceuticals Inc., Impax Laboratories, Lundbeck and Others Key Players
Here's Why Roche Stock May Continue To Trend Higher
08:30am, Monday, 15'th Nov 2021
Roche's ADR reported its Q3 results last month with the top-line expanding 8% y-o-y, led by a 29% growth in new pharmaceuticals products, 18% growth in diagnostics, and 5% growth in other pharmaceutic
Celltrions Truxima posts 46 percent market share in major European countries
07:33am, Monday, 15'th Nov 2021 KoreaHerald
South Korean pharmaceutical giant Celltrions Truxima, the first biosimilar of Roches blockbuster cancer dr
Roche ranked as one of the top three most sustainable healthcare companies in the Dow Jones Sustainability Indices for the thirteenth year running
06:00am, Monday, 15'th Nov 2021 Intrado Digital Media
Basel, 15 November 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) has again been recognised as one of the most sustainable companies in the Pharmaceuticals index of the Dow Jones Sustainability Indices (DJSI). This is based on an in-depth analysis of economic, social and environmental performance. The DJSI family of indices serves as a benchmark for investors who integrate sustainability considerations into their portfolios. Roche has maintained its leadership through its sustainability strategy, which is fully embedded in the companys business and culture. We are proud of being recognised once again for our consistent and lasting engagement on sustainability, says Roche CEO Severin Schwan. This achievement strongly resonates in the context of our 125-year anniversary, and highlights our heritage and our continued commitment to society. S ustainability at Roche For 125 years, sustainability has been an integral part of Roches business. Roche follows a holistic approach when managing sustainability: In addition to improving access to products, the companys strategy also focuses on achieving continuous progress in areas such as social responsibility, environmental protection, supply chain sustainability, people attraction and retention.
Plan for Roche gypsy camp recommended for approval
11:32am, Sunday, 14'th Nov 2021 Cornwall Reports
By Rashleigh MacFarlane Council officials are recommending approval of controversial plans for a gypsy camp at Roche. The site is just over an acre to the north of Tregoss Road. The planning application is for six pitches. Roche parish council has lodged an objection, saying the scheme is inappropriate but officials claim it would help []
Europe Approves Regeneron - Roche's COVID-19 Antibody Cocktail
01:00pm, Friday, 12'th Nov 2021
The European Commission (EC) has approved Regeneron Pharmaceuticals Inc's (NASDAQ: REGN) COVID-19 antibody cocktail, known as REGEN-COV in the U.S. and Ronapreve in the European Union (EU) and othe
Regeneron (REGN)-Roche COVID-19 Cocktail Gets Positive CHMP Opinion
11:33am, Friday, 12'th Nov 2021
Regeneron (REGN) and partner Roche obtain a positive opinion from CHMP for their antibody cocktail for the treatment of non-hospitalized patients with confirmed COVID-19 and to prevent the disease.
Sign In
Buy RHHBY